Expression of inducible nitric oxide synthase activity in human colon epithelial cells: Modulation by T lymphocyte derived cytokines

Gut

Volumn 43, Issue 1, 1998, Pages 56-63

  Kolios, G ^a   Rooney, N ^b   Murphy, C T ^a   Robertson, D A F ^b   Westwick, J ^a  

^a University of Bath ^*  (United Kingdom)

^b ROYAL UNITED HOSPITAL   (United Kingdom)

Author keywords

Colonic epithelial cells; Inducible nitric oxide synthase; Interleukin 13; Nitric oxide; Ulcerative colitis

Indexed keywords

CYTOKINE; MESSENGER RNA; NITRIC OXIDE SYNTHASE; NITRITE; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 10; RECOMBINANT INTERLEUKIN 13; RECOMBINANT INTERLEUKIN 1ALPHA; RECOMBINANT INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; COLITIS; COLON MUCOSA; CONTROLLED STUDY; ENZYME ACTIVITY; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; INTESTINE INFECTION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; ULCERATIVE COLITIS;

EID: 0031839897     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.43.1.56     Document Type: Article

References (56)

1. Moncada S, Higgs A. The L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
2. Nathan C, Qiao-wen X. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-8.
3. Michel T, Li GK, Busconi L. Phosphorylation and subcellular translocation of endothelial nitric oxide synthase. Proc Natl Acad Sci USA 1993;90:252-6.
4. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
5. Nakane M, Schmidt HHHW, Pollock JS, et al. Cloned human brain nitric oxide synthase is highly expressed in skeletal muscle. FEBS Lett 1993;316:175-80.
6. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109-12.
7. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukoc Biol 1993;54: 171-8.
8. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthase. Am J Physiol 1994;266: E829-39.
9. Whittle BJR. Nitric oxide in gastrointestinal physiology and pathology. In: Johnson LR, ed. Physiology of the gastrointestinal tract. 3rd ed. New York: Raven Press, 1994:267-94.
10. Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993;341:465-6.
11. Lundberg JON, Hellstrom PM, Lundberg JM, et al. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994;344:1673-4.
12. Boughton-Smith NK, Evans SM, Hawkey CJ, et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993;342:338-40.
13. Kolios G, Brown Z, Robson RL, et al. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-20. Br J Pharmacol 1995;116:2866-72.
14. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994;106:533-9.
15. Minty A, Chalon P, Derocq J-M, et al. Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 1993;362:248-50.
16. Zurawski G, De Vries JE. Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today 1994;15:19-26.
17. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction hy IFN-gamma plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995; 154:1870-8.
18. de Waal Malfyt R, Abrams J, Bennett B, et al. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-20.
19. Moore KW, O'Garra A, De Waal Malefyt R, et al. Interleukin-10. Annu Rev Immunol 1993;11:165-90.
20. Kasama T, Strieter RM, Lukacs NW, et al. Regulation of neutrophil-derived chemokine expression by IL-10. J Immunol 1994;152:3559-69.
21. Isaacs KL, Sartor RB, Haskill JS. Cytokine mRNA profiles in inflammatory bowel disease mucosa detected by PCR amplification. Gastroenterology 1992;103:1587-95.
22. Niessner M, Volk BA. Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR). Clin Exp Immunol 1995;101:428-35.
23. Kucharzik T, Stoll R, Lugering N, et al. Circulating antiinflammatory cytokine IL-10 in patients with inflammatory bowel disease (IBD). Clin Exp Immunol 1995;100: 452-6.
24. Radford-Smith D, McGowan I, Jewell DP. Th1 and Th2 gene expression in inflammatory bowel disease. Gastroenterology 1994;106:A757.
25. Radford-Smith D, Jewell DP. Cytokines and inflammatory bowel disease. Baillieres Clin Gastroenterol 1996;10:15164.
26. Kucharzik T, Lugering N, Weigelt H, et al. Immunoregulatory properties of IL-13 in patients with inflammatory bowel disease; comparison with IL-4 and IL-10. Clin Exp Immunol 1996;104:483-90.
27. Kucharzik T, Lugering N, Adolf M, et al. Synergistic effect of immunoregulatory cytokines on peripheral blood monocytes from patients with inflammatory bowel disease. Dig Dis Sci 1997;42:805-12.
28. Kahn R, Lohler J, Rennick D, et al. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993;75:263-74.
29. Rennick DM, Fort MM, Davidson NJ. Studies with IL-10 deficient mice: an overview. J Leukoc Biol 1997;61:389-96.
30. Singer II, Kawka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111:871-85.
31. Misko TP, Schilling RJ, Salvemini D, et al. A flourometric assay for the measurement of nitrite in biological samples. Anal Biochem 1993;214:11-16.
32. Strieter RM, Kunkel SL, Showell HJ, et al. Endothelial cell gene expression of a neutrophil chemotactic factor by TNE-α, LPS and IL-1β. Science 1989;243:1467-9.
33. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
34. Grisham MB, Miles AM. Effects of aminosalicylates and immunosuppressive agents on nitric oxide-dependent N-nitrosation reactions. Biochem Pharmacol 1994;47:1897-902.
35. Tepperman BL, Brown JE, Korolkiewicz R, et al. Nitric oxide synthase activity, viability and cyclic GMP levels in rat colonic epithelial cells: effect of endotoxin challenge. J Pharmacol Exp Ther 1994;271:1477-82.
36. Grisham MB. Oxidants and free radicals in inflammatory bowel disease. Lancet 1994;344:859-61.
37. Kitagawa H, Takeda F, Kohei H. Effect of endothelium derived relaxing factor on the gastric lesion induced by HCl in rats. J Pharmacol Exp Ther 1990;253:1133-7.
38. MacNaughton WK, Cirino G, Wallace JL. Endothelium relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989;4589:1869-76.
39. Hutcheson I, Whittle BJR, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990;101:815-20.
40. Hartley MG, Hudson MJ, Swarbrick ET, et al. The rectal mucosa-associated microflora in patients with ulcerative colitis. J Med Microbiol 1992;36:96-103.
41. Kwon NS, Stuehr DJ, Nathan CF. Inhibition of tumour cell ribonucleotide reductase by macrophage-derived nitric oxide. J Exp Med 1991;174:761-7.
42. Drapier JC, Hibbs JB. Murine cytotoxic activated macrophages inhibit aconitase in tumour cells. Inhibition involves the iron-sulfur prosthetic group and is reversible. J Clin Invest 1986;78:790-7.
43. Grisham MB, Ware K, Gilleland HE, et al. Neutrophil-mediated nitrosamine formation: a role of nitric oxide in rats. Gastroenterology 1992;103:1260-6.
44. MacNaughton WK. Nitric oxide-donating compounds stimulate electrolyte transport in the guinea pig intestine in vitro. Life Sci 1993;53:585-93.
45. Lichtman SN, Sartor RB. Examining the role of inflammatory cytokines in chronic inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1993;16:239-40.
46. Kolios G, Nakos A. Cytokines in inflammatory bowel disease. Hellenic Journal of Gastroenterology 1995;8: 117-25.
47. Doyle AG, Herbein G, Montaner LJ, et al. Interleukin-13 alters the activation state of murine macrophages in vitro: comparison with interleukin-4 and interferon-gamma. Eur J Immunol 1994;24:1441-5.
48. Doherty TM, Kastelein R, Menon S, et al. Modulation of murine macrophage function by IL-13. J Immunol 1993;151:7151-60.
49. Saura M, Martinez-Dalmau R, Minty A, et al. Interleukin-13 inhibits inducible nitric oxide expression in human mesangial cells. Biochem J 1996;313:641-6.
50. Oswald IP, Gazzinelli RT, Sher A, et al. IL-10 synergizes with IL-4 and transforming growth factor beta to inhibit macrophage cytotoxic activity. J Immunol 1992;148:3578-82.
51. Cenci E, Romani L, Mencacci A, et al. Interleukin-4 and interleukin-10 inhibit nitric oxide-dependent macrophage killing of candida-albicans. Eur J Immunol 1993;23:1034-8.
52. Kolios G, Robertson DAF, Jordan NJ, et al. Interleukin-8 production by the human colon epithelial cell line HT-29: Modulation by interleukin 13. Br J Pharmacol 1996;119: 351-9.
53. Schreiber S, Heinig T, Thiele H-G, et al. Immunoregulatory role of interleukin 10 in patients with inflammatory bowel disease. Gastroenterology 1995;108:1434-14.
54. Duchmann R, Schmitt E, Knolle P, et al. Tolerance towards resident intestinal flora in mice is abrogated in experimental colitis and restored by treatment with interleukin-10 or antibodies to interleukin-12. Eur J Immunol 1996;26:934-8.
55. McKenzie ANJ, Culpepper JA, De Waal Malefyt R, et al. Interleukin-13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 1993;90:3735-9.
56. De Waal Malefyt R, Figdor CG, Huijbens R, et al. Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes: comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 1993;151: 6370-81.